Sintesi Research Srl   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Milan Italy (1995)

Organization Overview

First Clinical Trial
2006
NCT00727324
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Sintesi Research Srl

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 2)

Cataract (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Cystic Fibrosis (Phase 1)

Fibrosis (Phase 1)

Hemophilia A (Phase 4)

Low Back Pain (Phase 2)

Nasal Obstruction (Phase 3)

Scleroderma, Diffuse (Phase 4)

Scleroderma, Localized (Phase 4)

Scleroderma, Systemic (Phase 4)

Sneezing (Phase 3)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 10